Innate and adaptive immunity in Candida albicans infections and saprophytism.
about
Candida albicans and Pseudomonas aeruginosa Interaction, with Focus on the Role of EicosanoidsCandida glabrata: new tools and technologies-expanding the toolkitInteraction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines.Virulence attenuation of Candida albicans genetic variants isolated from a patient with a recurrent bloodstream infection.Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients.Antigenic properties and processing requirements of 65-kilodalton mannoprotein, a major antigen target of anti-Candida human T-cell response, as disclosed by specific human T-cell clones.Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.Immune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4(+) T cells and possible participation of other local lymphocyte effectors.Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.Bilateral chronic fungal dacryocystitis caused by Candida dubliniensis in a neutropenic patientEffects of COX-2 inhibitor NS-398 on IL-10 expression in rat fungal keratitis.The roles of surfactant protein D during Aspergillus fumigatus infection in human corneal epithelial cellsInvestigating the function of Ddr48p in Candida albicansParenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis.The Candida albicans ATO Gene Family Promotes Neutralization of the Macrophage PhagolysosomeArachidonic acid metabolites in pathogenic yeasts.Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice.Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunityCandida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine.Host-pathogen interaction and signaling molecule secretion are modified in the dpp3 knockout mutant of Candida lusitaniaeCell surface changes in the Candida albicans mitochondrial mutant goa1Δ are associated with reduced recognition by innate immune cells.Parenteral administration of medium- but not long-chain lipid emulsions may increase the risk for infections by Candida albicans.Impairment of host defense against disseminated candidiasis in mice overexpressing GATA-3Candida albicans yeast and germ tube forms interfere differently with human monocyte differentiation into dendritic cells: a novel dimorphism-dependent mechanism to escape the host's immune response.Total-Body Irradiation Exacerbates Dissemination of Cutaneous Candida Albicans Infection.Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells.
P2860
Q26767229-A8D7A7C3-46A7-4D56-8DD3-928E827B31BBQ26800080-4025C662-7B00-4F8D-B5AE-7599B0A8C5D1Q30479433-0966442F-5C4C-46CF-AA9E-FABFBADAF5F6Q33559838-4C9220A1-3F2F-462E-A18A-F4615B581A90Q33758772-1D1916A2-2A0C-43F8-BFCE-9124AA9C1DACQ34007719-FBD052B2-EB7B-4E0D-89B3-39D812B9E3ACQ34008664-C2D07F05-46CF-4DDE-9B8A-25AFB234D454Q34130381-7F825E1A-FD16-4EBB-9CEB-E61A4FDE47F2Q34131697-823B25C1-3D5F-42A0-B538-88994294B857Q34259300-203CB56F-BB64-4A18-A713-5A5DA5942F48Q35770376-27133642-9137-4B65-8F5E-8BF42A2B47E7Q35923915-AE096A57-C917-4F42-AACE-0CBC59BA05E3Q35924218-50375231-6903-4F91-ACAA-2C5919877C51Q36017815-4B0373FA-3002-427D-8B44-CFBFD04175C3Q36046183-0BD1ED8C-0C15-490D-BDD6-D0E056C5BA44Q36138048-6054F911-76A2-483D-9A79-B9F88CAABB3FQ36329171-A04ABA34-72FD-4064-A2EB-65AFAC939EADQ36422137-C0D7BDA2-F1CA-42BA-9134-90212FB949FCQ37280340-D804A7C1-C94D-4955-B049-3FAE9834F03FQ37377608-6C5730E9-73A1-468E-A827-76751B0748A6Q37548161-2D9230C2-4A8F-4961-B638-7C8088C09B27Q39181204-0EA67C97-0000-4D9E-8ACC-983315DB722FQ39663602-F7FA9959-26EC-4DDE-BBC1-F3A5A6544610Q40332012-A318A459-2144-444A-A8F6-F175B38AE0F9Q40469665-34CB1D73-4280-4769-A59E-8594F44528D6Q40515129-12C5BBE9-0969-48F4-9AF3-6F64E6D23BCFQ42012476-3C069A0E-24D6-43AA-9BC7-2CE4EA68F4C3
P2860
Innate and adaptive immunity in Candida albicans infections and saprophytism.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Innate and adaptive immunity in Candida albicans infections and saprophytism.
@ast
Innate and adaptive immunity in Candida albicans infections and saprophytism.
@en
Innate and adaptive immunity in Candida albicans infections and saprophytism.
@nl
type
label
Innate and adaptive immunity in Candida albicans infections and saprophytism.
@ast
Innate and adaptive immunity in Candida albicans infections and saprophytism.
@en
Innate and adaptive immunity in Candida albicans infections and saprophytism.
@nl
prefLabel
Innate and adaptive immunity in Candida albicans infections and saprophytism.
@ast
Innate and adaptive immunity in Candida albicans infections and saprophytism.
@en
Innate and adaptive immunity in Candida albicans infections and saprophytism.
@nl
P1476
Innate and adaptive immunity in Candida albicans infections and saprophytism
@en
P2093
P304
P577
2000-08-01T00:00:00Z